Mon, 5 October 2020
I’m the host of Investor Connect, Hall T Martin, where we connect startups and investors for funding.
Therapeutics continues to advance across the board. In today’s show, you’ll hear about a new company in the pharma space called BiorganicPharma who develop and make nutritional supplements in liquid form using natural ingredients.
Our show host today is Ashley Matthysse.
Our featured guests are:
Jackie Kapur, Strategic CFO - https://in/jacqueline-kapur-49b1b81/
Dr. Simon Mills, Chief Investment Officer - https://in/drmills/
Through her 15-year corporate finance career, Jackie has a proven track record of formulating and executing strategies & budgets for both start-ups and established businesses. She is a thoughtful and experienced leader in finance, business development, operation, marketing, and HR across industries including information technology, news, research, data, financial services, and consumer products. Excellent communication and people skills with significant experience navigating C-level management through major strategic changes.
Simon is a skilled and successful entrepreneur with over thirty years of business experience. Born in Perth Western Australia in 1967 Dr. Mills studied at the Conservatorium of Music in New South Wales and went on to become a piano tuner/restorer, tour with many successful rock bands, and to host a radio program that became nationally syndicated. Mills founded London Music Group (LMG) with business partner Wazza Bray in 1990 and grew that company to the number one commercial music house in the country winning award after award and culminating in the world’s best jingle award. In 2006, with several successful startups completed, Simon moved from Australia to New York City with his wife and three children. Simon grew LMG Digital Media in the US to attract customers as significant as Hyatt, AIG, BBDO, CBS, Starbucks, Pepsi, The Economist and many more.
I hope you enjoy this episode.
Check out our other podcasts here: https://investorconnect.org/
Direct download: Intro_to_BiorganicPharma_WEBINAR_to_IC_Sector_Review_FINAL.mp3
Category: -- posted at: 9:57am CDT
Mon, 5 October 2020
Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing.
In launching your fundraise, you should always be in a position to take funding. There are many investors who want to join the deal but won’t take on a lead investor role in setting the terms.
A convertible note works well for this stage of the raise. It’s a debt instrument that converts to equity later, so there’s no valuation to negotiate.
Startups can accept investors into the deal with relative ease, given most notes have simple terms, rights, and conditions.
The note is on a rolling close. So the investor signs the check, the startup signs the note, and the funding goes into the business the next day.
One can use the note over several smaller fundraises to gather investor funds.
When setting up a convertible note, consider what will happen upon conversion to the cap table.
Startups should take care not to raise too much funding off convertible notes.
In later stages, such as raising a Series A, investors are going to want a certain amount of ownership in the deal. If there is too much convertible debt, then it will be difficult to give the investor the ownership they want.
Direct download: Startup_Funding_Espresso_--_Using_Convertible_notes_wisely.mp3
Category:general -- posted at: 6:34am CDT